Literature DB >> 20085314

Reversibility of beta-amyloid self-assembly: effects of pH and added salts assessed by fluorescence photobleaching recovery.

Nadia J Edwin1, Robert P Hammer, Robin L McCarley, Paul S Russo.   

Abstract

The 40-residue peptide isoform beta-amyloid (Abeta(1-40)) is associated with Alzheimer's disease. Although found in the tangles and fibrous mats that characterize the brain in advanced stages of the disease, the toxic form of Abeta is believed to be oligomers or "protofibrils". Characterization of these fairly small structures in solution, especially in the presence of the much larger assemblies they also form, is a daunting task. Additionally, little is known about the rate of Abeta assembly or whether it can be triggered easily. Perhaps most importantly, the conditions for reversing assembly are not fully understood. Fluorescence photobleaching with modulation detection of the recovery profile is a sensitive and materials-efficient way to measure diffusers over a wide range of hydrodynamic sizes. The method does require attachment of a fluorescent label. Experiments to validate the use of 5-carboxyfluorescein-labeled Abeta(1-40) as a representative of the unlabeled, naturally occurring material included variation of photobleaching time and mixture of labeled and unlabeled materials. A dialysis cell facilitated rapid in situ changes in pH and salt conditions. Multiple steps and complex protocols can be explored with relative ease. Oligomeric aggregates were found by fluorescence photobleaching recovery to respond readily to pH and salt conditions. Changing these external cues leads to formation or disassembly of aggregates smaller than 100 nm within minutes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20085314      PMCID: PMC2859319          DOI: 10.1021/bm900833b

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  33 in total

1.  Amyloid-beta peptide assembly: a critical step in fibrillogenesis and membrane disruption.

Authors:  C M Yip; J McLaurin
Journal:  Biophys J       Date:  2001-03       Impact factor: 4.033

2.  Synthesis and fluorescent labeling of beta-amyloid peptides.

Authors:  L Fülöp; B Penke; M Zarándi
Journal:  J Pept Sci       Date:  2001-08       Impact factor: 1.905

3.  Kinetic analysis of beta-amyloid fibril elongation.

Authors:  Michelle J Cannon; Angela D Williams; Ronald Wetzel; David G Myszka
Journal:  Anal Biochem       Date:  2004-05-01       Impact factor: 3.365

4.  Temperature dependence of amyloid beta-protein fibrillization.

Authors:  Y Kusumoto; A Lomakin; D B Teplow; G B Benedek
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

5.  Simulation study of the structure and dynamics of the Alzheimer's amyloid peptide congener in solution.

Authors:  F Massi; J W Peng; J P Lee; J E Straub
Journal:  Biophys J       Date:  2001-01       Impact factor: 4.033

6.  Kinetic modeling and determination of reaction constants of Alzheimer's beta-amyloid fibril extension and dissociation using surface plasmon resonance.

Authors:  Kazuhiro Hasegawa; Kenjiro Ono; Masahito Yamada; Hironobu Naiki
Journal:  Biochemistry       Date:  2002-11-19       Impact factor: 3.162

7.  Studies on the in vitro assembly of a beta 1-40: implications for the search for a beta fibril formation inhibitors.

Authors:  C S Goldsbury; S Wirtz; S A Müller; S Sunderji; P Wicki; U Aebi; P Frey
Journal:  J Struct Biol       Date:  2000-06       Impact factor: 2.867

8.  Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-beta protein.

Authors:  J D Harper; C M Lieber; P T Lansbury
Journal:  Chem Biol       Date:  1997-12

9.  Stoichiometric inhibition of amyloid beta-protein aggregation with peptides containing alternating alpha,alpha-disubstituted amino acids.

Authors:  Marcus A Etienne; Jed P Aucoin; Yanwen Fu; Robin L McCarley; Robert P Hammer
Journal:  J Am Chem Soc       Date:  2006-03-22       Impact factor: 15.419

Review 10.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

View more
  5 in total

Review 1.  Biochemistry of amyloid β-protein and amyloid deposits in Alzheimer disease.

Authors:  Colin L Masters; Dennis J Selkoe
Journal:  Cold Spring Harb Perspect Med       Date:  2012-06       Impact factor: 6.915

Review 2.  FRAP in pharmaceutical research: practical guidelines and applications in drug delivery.

Authors:  Hendrik Deschout; Koen Raemdonck; Jo Demeester; Stefaan C De Smedt; Kevin Braeckmans
Journal:  Pharm Res       Date:  2013-09-10       Impact factor: 4.200

Review 3.  Biomolecular condensates at the nexus of cellular stress, protein aggregation disease and ageing.

Authors:  Simon Alberti; Anthony A Hyman
Journal:  Nat Rev Mol Cell Biol       Date:  2021-01-28       Impact factor: 94.444

4.  Characterization of the interaction of β-amyloid with transthyretin monomers and tetramers.

Authors:  Jiali Du; Regina M Murphy
Journal:  Biochemistry       Date:  2010-09-28       Impact factor: 3.162

Review 5.  Recent applications of fluorescence recovery after photobleaching (FRAP) to membrane bio-macromolecules.

Authors:  Gamal Rayan; Jean-Erik Guet; Nicolas Taulier; Frederic Pincet; Wladimir Urbach
Journal:  Sensors (Basel)       Date:  2010-06-10       Impact factor: 3.576

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.